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affective memory via vagal afferent pathway in
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Background: Pain contains both sensory and affective dimensions. Using a rodent visceral pain assay that
combines the colorectal distension (CRD) model with the conditioned place avoidance (CPA) paradigms, we
measured a learned behavior that directly reflects the affective component of visceral pain, and showed that
perigenual anterior cingulate cortex (pACC) activation is critical for memory processing involved in long-term
visceral affective state and prediction of aversive stimuli by contextual cue. Progress has been made and suggested
that activation of vagal afferents plays a role in the behavioral control nociception and memory storage processes.
In human patients, electrical vagus nerve stimulation enhanced retention of verbal learning performance.
Cholecystokinin-octapeptide (CCK), which is a gastrointestinal hormone released during feeding, has been shown to
enhance memory retention. Mice access to food immediately after training session enhanced memory retention. It
has been well demonstrated that CCK acting on vagal afferent fibers mediates various physiological functions. We
hypothesize that CCK activation of vagal afferent enhances visceral pain-related affective memory.
Results: In the presented study, infusion of CCK-8 at physiological concentration combining with conditional
training significantly increased the CRD-induced CPA scores, and enhanced the pain affective memory retention. In
contrast, CCK had no effect on CPA induced by non-nociceptive aversive stimulus (U69,593). The physiological
implications were further strengthened by the similar effects observed in the rats with duodenal infusion of 5%
peptone, which has been shown to induce increases in plasma CCK levels. CCK-8 receptor antagonist CR-1409 or
perivagal application of capsaicin abolished the effect of CCK on aversive visceral pain memory, which was
consistent with the notion that vagal afferent modulates affective aspects of visceral pain. CCK does not change the
nociceptive response (visceral pain sensitivity) and anterior cingulate cortex neuronal responses to CRD.
Conclusion: CCK activating vagal afferent C fibers enhances memory consolidation and retention involved in
long-term visceral negative affective state. Thus, in a number of gastrointestinal disorders, such as irritable bowel
syndrome, nutrient content may contribute to painful visceral perception by enhancing visceral aversive memory
via acts on vagal afferent pathway.
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The conceptualization of pain in humans recognizes sev-
eral interrelated components. The components involves
the encoding and perception of stimulus parameters
(e.g., stimulus localization, intensity, and quality), and
the component involves the encoding of the affective sa-
lience or unpleasantness of the noxious stimulus [1].
Teasing apart the mechanisms that control the neural
pathways mediating pain affect and sensation in noci-
ceptive behavioral response is a challenge. Our series of
publications have demonstrated that perigenual ACC
(pACC) plays a critical role in the modulation of sensory
aspect of visceral pain in viscerally hypersensitive rats
[2-4]. The ACC has been proposed to process informa-
tion relating to pain- unpleasantness, and contribute to
the avoidance learning that sometimes follows as a sec-
ondary reaction to pain [5]. One of the first studies using
a rodent visceral pain assay that combines the colorectal
distension (CRD)-induced visceromotor response (VMR)
with the conditioned place avoidance (CPA), we mea-
sured a learned behavior that directly reflects the
affective component of visceral pain [6]. When CRD was
paired with a distinct environment context, the rats
spent significantly less time in this compartment on the
post-conditioning test days as compared with the pre-
conditioning day. Effects were lasted for several days.
Lesions of pACC or administration of glutamate recep-
tors antagonists abolished CRD-induced CPA; these data
indicated that pACC activation is critical for the memory
processing involved in long-term negative affective state
and prediction of aversive stimuli by contextual cue [6].
Physiological and psychological events can either
strengthen or weaken the formation of memories. Pro-
gress has been made and suggested that activation of
vagal afferents plays a role in the behavioral control of
nociception [7] and memory storage processes [8,9].
Clark et al [8] have shown that electrical vagus nerve
stimulation (VNS) given immediately after training
enhanced retention performance on an inhibitory-avoid-
ance task in rats. In human patients VNS at an intensity
similar to that effect in rodent enhanced retention of
verbal learning (word recognition) performance [10].
Subdiaphragmic vagotomy attenuates the memory
modulation produced by post-training systemic injec-
tions of various substances [11], including 4-OH am-
phetamine, leu-enkephalin [12], and substance P [13].
Cholecystokinin (CCK) is a gastrointestinal hormone
released during feeding [14-16]. Electrophysiological and
functional studies have demonstrated that CCK recep-
tors in the vagal afferent fibers mediate various physio-
logical functions [17-20]. Based on findings in rats and
human, we hypothesize that CCK activation of vagal af-
ferent facilitates the visceral pain memory consolidation
involved in long-term negative affective state.The current study used colorectal distension (CRD)-
induced visceral pain with the conditioned place avoidance
(CPA). We examined the learned behavior and aversive
memory in conscious rats. In combination with CRD-CPA
with administration of CCK this approach enables one to
determine whether CCK modulates “aversiveness memory”
of visceral pain. One question addressed in the current
study concerns whether CCK-induced enhancement of
affective component of pain memory is specifically with
aversiveness of visceral nociceptor-activating stimuli, or is
associated with aversive stimuli in general. We examined
the effects of CCK on CPA induced by an aversive, but
non-nociceptive-activating stimulus κ-opioid receptor
agonist U69,593 [21]. To identify the role of vagal afferent
C-fibers in the mediation of CCK’s action perivagal capsa-
icin studies were performed. To determine if endogenously
released CCK also acts on capsaicin-sensitive vagal afferent
to enhance pain memory, we showed that the similar
effects were observed following intra-duodenal perfusion of
peptone, which has been shown to postprandial release en-
dogenous CCK [16,22]. The nociceptive response (viscero-
motor response [VMR]) to CRD was recorded to clarify
that administration of CCK does not alter the visceral pain
sensitivity. Our recent studies showed that ACC activation
was critical for the memory processing involved in visceral
long-term negative affective state [6], however, electro-
physiological recording of pACC neurons showed that ad-
ministration of CCK did not change the ACC responses to
CRD.
Results
Effects of CCK-8 on colorectal distention induced
conditioned place avoidance (CRD-CPA)
Pain contains both sensory and affective dimensions. Ex-
cept for human experiments where self report is possible,
teasing apart the mechanisms that control the neural
pathways mediating pain affect and sensation in an overall
animal nociceptive behavioral response is a challenge. We
measured a learned behavior that directly reflects the
affective component of visceral pain (CRD-induced CPA)
[6]. We hypothesize that CCK activation of vagal afferent
enhances visceral pain-related affective memory.
In all groups of rats, no initial preference for any of the 3
compartments in the place conditioning apparatus was
detected on the pre-conditioning test day. When CRD (40
mm Hg) was paired with a particular compartment in the
place-conditioning apparatus all rats spent significantly less
time in this compartment on the post-conditioning test
days compared with the pre-conditioning test day. In con-
trol rats (with saline infusion), significant effects on the
magnitudes of CPA scores (pre-conditioning minus post-
conditioning) were lasted for 3 days. However, the rats with
intravenous infusion of CCK-8 (40 pmol/kg/h for 15 min)
immediately following CRD-conditioning training displayed
Figure 1 CPA in control and CCK-8 infusion rats with or without CCK-A-R antagonist or capsaicin pretreatment. (A) For the CPA score
the amount of time spent in the conditioning compartment on the post-conditioning days were subtracted from the amount of time spent in
the same compartment on the pre-conditioning day. The rats spent less time in this compartment on the post-conditioning test day as
compared with the pre-conditioning test day. Compared with control rats, intravenous infusion of CCK-8 after conditioning training markedly
increased the CPA scores in post-conditioning day 1, 3 and 5, respectively. This effect was blocked by pretreatment of CCK-A receptor antagonist
CR-1409. (B) Perivagal capsaicin treatment in control rats with saline infusion had no effect on CPA scores but eliminated the enhanced CRD-
induced CPA in rats with CCK-8 infusion. For easy and clear comparison, the same control group and CCK-8 group were used here as in Figure 1
A. Results were presented as means ± SE. Statistical significance was determined by Two-way Repeated measurement ANOVA followed by
Bonferroni posttests. * P < 0.05, ** P < 0.01 compared between CCK-8 treatment group and control group, n=5 for each group.
Figure 2 CPA in control and peptone infusion rats with or
without CCK-A-R antagonist or capsaicin pretreatment. For the
CPA score the amount of time spent in the conditioning
compartment on the post-conditioning days were subtracted from
the amount of time spent in the same compartment on the pre-
conditioning day. Compared with control rats, intraduodenal
infusion of 5% peptone (3 ml in 15 min) after conditioning trainings
significantly increased CPA scores in post-conditioning day 1 and 5,
respectively. The enhanced effects of peptone infusion on CRD-
induced CPA were blocked by pretreatment of CCK-A receptor
antagonist CR-1409 or perivagal capsaicin application. Results were
presented as means ± SE. Statistical significance was determined by
Two-way Repeated measurement ANOVA followed by Bonferroni
posttests. ** P < 0.01, *** P < 0.001 compared between peptone
infusion group and control group, n=5 for each group.
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cant effects lasted for 5 days compared to 3 days in the con-
trol rats. The scores of rats in these studies are shown in
Figure 1A. (Ftime (3,36) =63.09, Ftreatment (2,36) =13.45; n=5 for
each group, Figure 1A). These observations suggest that
post-training administration of CCK enhances the aversive
emotional responses of visceral pain, and further prolongs
the visceral pain memory. Administration of CCK-A recep-
tor antagonist CR-1409 (10 mg/kg iv) abolished the effects
of CCK on pain memory. The magnitudes of CPA scores
were reduced (Figure 1A).
To identify the sites of action of CCK to enhance vis-
ceral pain memory we performed perivagal capsaicin
study, which abolished vagal nerve C fibers [17,20,23,24].
Perivagal capsaicin treatment had no effect on the magni-
tudes of CPA scores in the control rats. In contrast, peri-
vagal application of capsaicin eliminated the effects of
CCK on facilitating CRD-induced aversive aspect of vis-
ceral pain memory (Figure 1B) suggesting CCK acts on
vagal capsaicin-sensitive C-fibers to enhance visceral aver-
sive pain memory.
Effects of peptone perfusion on visceral pain-induced
conditioned place avoidance (CPA)
Although exogenously infused CCK facilitates CRD-induced
aversive aspect of visceral pain memory, the physiological
implication of postprandial released CCK is unclear. Previ-
ously, we have shown that intraduodenal perfusion of 5%
peptone increased plasma CCK levels by stimulating CCK-
releasing peptide (CCK-RP) secretion [16]. Here, we
reported that intra-duodenal infusion of 5% peptone (3ml
for 15 min) after CRD training increased the magnitudes of
CPA scores (Figure 2). The significant effect maintained for
5 days (FTime (3, 48) =165.38, FTreatment (3, 48) = 9.29; n=5 foreach group). Administration of CCK-A receptor antagonist
CR-1409 (10 mg/kg i.v.) abolished the effects of intra-duo-
denal perfusion of peptone. The CR-1409 treated rats dis-
played significantly lower magnitudes of CPA scores
(Figure 2). Further, perivagal capsaicin pretreatment elimi-
nated the effects of peptone on the increases of the CPA
scores induced by visceral pain simulation (Figure 2). These
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CCK, which acts on capsaicin-sensitive vagal afferent fibers
to enhance visceral pain affection and prolong the aversive
pain memory.Effects of CCK-8 on U69,593-induced CPA
To clarify whether the effects of CCK-8 on enhancing pain
memory are specifically associated with the aversiveness of
visceral nociceptor-activating stimuli or with aversive stim-
uli in general, we examined the effects of CCK on CPA
induced by an aversive, but non-nociceptive-activating
stimulus.
Mu-opioid receptor agonists function as rewarding
stimuli, whereas agonists at kappa-opioid receptors in-
duce aversive states. These motivational effects have
been attributed to interactions of exogenous opioids
with endogenous reward pathways in the brain. The
kappa-opioid receptor agonist U69,593, which is known
to be aversive [21] when injected systemically, was admi-
nistrated (s.c.) and paired with a distinct compartment
in the apparatus. The conditioning procedure was simi-
lar to that used in the CRD-induced CPA. The scores of
rats in these studies are shown in Figure 3. Unlike the
CRD-induced CPA (Figure 1A), post training CCK-8 ad-
ministration did not change the systemic U69,593-
induced CPA responses profiles (Figure 3). Therefore,
post training CCK-8 administration did not have a gen-
eral enhancement on learning in the place-conditioning
paradigm, but it markedly increases the magnitudes of
aversiveness of visceral pain, and prolongs the visceral
pain memory.Figure 3 CPA produced by the κ-opioid receptor agonist
U69,593 in control and CCK-8 infusion rats. For the CPA score
the amount of time spent in the conditioning compartment on the
post-conditioning days were subtracted from the amount of time
spent in the same compartment on the pre-conditioning day.
Compared with control rats, no significant differences of CPA scores
were observed in the rats with post training CCK-8 infusion. Results
were presented as means ± SE. Statistical significance was
determined by Two-way Repeated measurement ANOVA followed
by Bonferroni posttests, n=5 for each group.CCK-8 and peptone administration did not affect
visceromotor responses (VMR) to distension
To clarify if post-training administration of CCK-8 or pep-
tone increase the sensory aspect of visceral pain (pain sen-
sitivity), which results in facilitation of affective aspect of
pain memory, we tested the CRD-induced visceromotor
response after CCK-8 or peptone administration. The
VMR induced by CRD is a brain stem-mediated reflex
contraction of the abdominal musculature.
In response to stimuli that cause pain, all animals show
musculoskeletal and autonomic responses, the so-called
pseudoaffective reflex responses [25]. The results are
shown in the Figure 4. Compared to the control group ad-
ministration of CCK-8 or intra-duodenal perfusion of pep-
tone had no effects on VMR to colorectal distension.
These observations indicated that the roles of CCK toFigure 4 VMR to graded pressure CRDs in control rats, CCK-8
infusion and 5% peptone infusion rats. (A) Representative
abdominal muscle electromyograms of the VMR to graded-pressure
CRD (20, 40 and 60 mmHg) recorded from the external oblique
pelvic muscle in normal rats and rats with CCK-8 and peptone
infusion. No obvious difference was found among the three groups.
(B) Histograph showed the effects of CCK infusion and 5% peptone
infusion on the VMR to graded-pressure CRD in rats. Mean
amplitude of the abdominal muscle contraction expressed as AUC
after baseline subtraction was presented. No significant difference
was found among the three groups. Results were expressed as
means ± SE. Statistical comparisons of the VMR in various groups
were made by two-way repeated-measures ANOVA, followed by
multiple comparisons adjusted by the Bonferroni test, n=5 for each
groups.
Figure 5 Neuronal activities of CRD-excited ACC neurons in
response to CRD in CCK-8 infusion rats. (A) Recording of a 50
mmHg colorectal distension (CRD)-excited ACC neuron in a control
rat and a rat with CCK-8 infusion. In control rats, the responses to 50
mmHg CRD were tested twice (first test and second test) and the
results showed that the responses were stable and repeatable. In
CCK-8-treated group, CCK-8 infusion did not change ACC
spontaneous neuronal firing and the spike firing rates in response to
50 mmHg CRD compared with saline infusion. (B) Histograph shows
that the spontaneous firing of CRD-excited neurons of ACC and
spike firing rates in response to CRD pressures (50 mmHg) was not
changed in rats treated with CCK-8 compared with saline. Results
were expressed as means ± SE. Statistical comparisons between
control and CCK-8-treated rats were made by Student’s t-test.
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ing the behavioral visceral pain responses (pain intensity)
in the rats under physiological condition.
ACC neuronal responses to colorectal distension (CRD)
Our series of published observations characterized
neural electrophysiological activity of ACC during pro-
cessing of visceral nociceptive stimulation [3,4,26]. It has
been well documented that the ACC is involved in pain
processing and encoding of negative affects in humans,
which results in pain-related unpleasantness. Recently,
performing CRD-induced CPA studies we demonstrated
that perigenual ACC activation is critical for the memory
processing involved in long-term visceral negative
affective state [6]. In this study to examine whether CCK
alters the ACC neuronal responses induced by visceral
nociceptive stimulation, which in turn to enhance aver-
sive pain memory, we performed electrophysiological
recording of ACC neurons in response to CRD in the
vehicle infusion and in combined with CCK-8 infusion.
Control
Total of 25 rats were examined for their response to CRD
(50 mmHg) with intravenous (i.v,) saline infusion. One
neuron per rat was labeled with neurobiotin. Neurobiotin
labeling failed in 4 of 25 rats. Of these 4 rats, the juxtacellu-
lar configurations were lost during the injection in three
rats, and histological studies revealed an absence of stained
cells in 1 rat, presumably because neurobiotin was depos-
ited extracellularly. These rats were excluded from further
study. Histological localization of the CRD-responsive neu-
rons showed that the recording electrodes were successfully
placed in the ACC of 21 rats. All of the recordings had uni-
form spike amplitude and could be minimized and sepa-
rated from the recordings of the neighboring neurons.
From these 21 rats seventy four neurons were recorded.
ACC spontaneous activity was monitored for 2 min to con-
firm the stability of basal firing frequency. Basal ACC neur-
onal firing rate was assessed over 30s to quantify the
resting discharge. Among the 74 neurons, 50 showed no re-
sponse to CRD (67.5%), and were referred to as CRD-non-
responsive; twenty one of 74 neurons (28%) exhibited an
excitatory response characterized by increased spike firings
from baseline 0.862 ± 0.036 to 1.680 ± 0.041 and thus were
referred to as CRD excited neurons. Histological
localization of the CRD-excited neurons showed that they
were located in the cingulate cortex area 1 (Cg1) and the
prelimbic (PrL) cortex. Three of 74 neurons were inhibited
by 50 mmHg CRD (CRD-inhibited neurons). These CRD-
inhibited neurons were not tested further. Consistent with
our previous observation [26], in the current study, the
CRD-excitatory neurons responding to 50 mmHg CRD
were tested twice and the results showed that the responses
were consistent and repeatable (Figure 5A).ACC neuronal responses to CRD in rats with CCK-8 infusion
A total of 28 rats with CCK-8 infusion were studied for
the spontaneous firing and the response to 50 mmHg
CRD in ACC. On completion of the experiment, during
the injection of neurobiotin, the juxtacellular configura-
tions were lost in three rats. Histology studies revealed
an absence of stained cells in one rat. The data from
Figure 6 Location and labeling of identified anterior cingulate cortex neurons with neurobiotin. (A) Location of neurons recorded in the
anterior cingulate cortex (ACC). Coronal sections from the caudal to rostral regions of the ACC (i.e., bregma 2.16, 2.76, 3.72 mm) show the
electrophysiological recording sites. Squares and circles indicate CRD-excited ACC neurons in control rats and CCK-8 treated rats, respectively. Cg,
cingulum; Cg1, cingulate cortex, area 1; Cg2, cingulate cortex, area 2; M2, Secondary motor cortex; PrL, prelimbic cortex. (B) Microphotograph of
neurons in the ACC labeled with neurobiotin a, thionine-stained coronal section shows the distribution of CRD-excited neurons in the ACC. b,
higher magnification of the neurobiotin-labeled pyramidal ACC neuron in a (arrow). Scale bars: a, 250 μm; b, 50μm.
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were successfully placed in the ACC of 24 rats in the
cingulate cortex area 1 (Cg1) and the prelimbic cortex
(Figure 6A). From these 24 rats, forty three neurons
were identified. Three types of neurons were classified
according to their CRD response: 19 of 43 (44%) were
CRD-non-responsive and 24 of 43 (56%) were activated
by CRD. Six of 24 neurons were inhibited by 50 mmHg
CRD (CRD-inhibited neurons). These CRD-inhibited
neurons were not tested further. Of the 24 CRD-activated
neurons, 18 of 24 neurons were 50 mmHg CRD-excited
neurons. The ACC spontaneous neuronal firing and
spike firings in response to 50 mmHg CRD with saline
infusion were 0.847 ± 0.034 and 1.690 ± 0.045 spikes/
s, respectively. When simultaneously infused with
CCK-8, the average spontaneous activity recorded inthe CRD-excitatory neurons was 0.840± 0.03 spikes/s.
The ACC spike firings in response to 50 mmHg CRD
increased to 1.662 ± 0.045 spikes/s. Original action po-
tential recordings are presented in Figure 5A. Mean
neuronal firing frequencies are shown in Figure 5B.
These results suggest that compared with saline infu-
sion CCK had no effects on ACC neuronal spontan-
eous activity, and did not alter the neuronal firings in
response to colorectal distension. Therefore, it appears
unlikely that the enhancement of pain memory by
CCK infused following conditional training is mediated
by modulating ACC neurons activations.
Discussion
Pain contains both sensory and affective dimensions.
Studies of the perception of unpleasantness are only
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possible, whereas the neural substrates of learning and
motivated behavior are more easily studied in animals.
Recently, we used behavioral paradigms visceromotor
responses (VMR) evoked by colorectal distention (CRD)
to assess visceral pain in the conscious rat [2,3]. Using
such tasks and models, we have shown that CRD
induced conditioned place avoidance (CPA) when paired
with a distinct environment context [6]. In conditioned
avoidance procedures, animal avoids stimuli based on the
formation of a negative association between the given
stimuli and the environment. This tendency for animal
to avoid environmental cues that have been deemed
aversive is believed to be affective important [27].
Current study used three days conditioning protocol;
we were able to show that a negative affective state was
maintained for 3 days following acute visceral pain insult
in the absence of further conditioning. These results are
consistent with the notion that acute pain insult leads to
the persistence of negative affective state. It is particu-
larly interesting in light of clinical data, which indicates
how the emotional or motivational effects of visceral
pain may live much longer than the pain itself [28].
Physiological and psychological events can either
strengthen or weaken the formation of memories. In the
animal and human, available evidences indicated that
vagal nerve stimulation enhanced memory and attention
[8,10,29]. Several studies have shown that subdiaphrag-
mic vagotomy attenuates the memory modulation pro-
duced by post-training systemic injections of various
substances, including 4-OH amphetamine, Leu-
enkephalin [12], and substance P [13]. These findings
suggest that peripherally acting substances may modu-
late memory storage processes via the activation of per-
ipheral receptors that send neural messages to the brain
via the vagus nerve.
An elegant study have demonstrated that when mice
were fed immediately after aversive T-maze training,
they remembered that task better than when access to
food was delayed and intraperitoneally administration of
CCK-8 enhanced memory retention in the mice after
aversive training [19]. Similarly, when humans are fed
immediately after learning, they have better recall of a
complex task 48 hours later. Children who have a 63%
increase in the amount eaten at breakfast have enhanced
short-term memory [30]. Cholecystokinin-octapeptide
(CCK-8), is a gastrointestinal hormone released during
feeding [16,22]. Electrophysiological studies in rats have
provided evidence that CCK stimulates vagal afferent
[18,23] to induce satiety [31] and decrease gastric empty-
ing [17].
The formation of memories was strengthened by
physiological and psychological events. Some of these
events may occur immediately before or during theperception of a stimulus, enabling an organism to learn
about it more efficiently [32]. In contrast, arousal may
also occur shortly following a learning experience, that
is, during memory consolidation [33]. The current study
demonstrated that intravenous infusion of CCK at
physiological doses [20] immediately following a visceral
aversive learning experience (colorectal distension),
improved conditional place avoidance performance in
rats suggesting that activations of CCK during the mem-
ory consolidation period were capable to enhance mem-
ory storage, rather than the acquisition, of the
information. The increases in CPA scores maintained for
5 days compared with 3 days in the rats subjected to
sham treatment. The higher CPA scores throughout the
post-conditioning days suggests the higher degree of
aversiveness, which may mimic the serious negative
affective state in human and decrease pain tolerance.
The vagus nerve, like all cranial nerves, contains three
types of fibers (A–C), distinguished by their physical and
electrical conductance properties. We have demon-
strated previously, that subdiaphragmatic electric vagal
stimulation reduced pain [7], this effect only occurred
through stimulation of Aδ-fibers and was absent when
C-fibers were stimulated. Capsaicin is a specific activator
of the transient receptor potential vanilloid type 1
(TRPV1) channel, a polymodal nociceptive transducer
expressed predominantly in non-myelinated sensory
afferents. Perivagal application of capsaicin has been
shown to inhibit axonal transport of peptides including
substance P and somatostatin [24,34]. Our published
data have demonstrated that CCK-8 at physiological
levels stimulated vagal afferent neurons, which in turn
stimulated pancreatic secretion via a vago-vagal reflex
[20,35]. Perivagal capsaicin treatment abolished CCK-8
stimulated vagal afferent neuronal responses and pancre-
atic secretion [20,23,24,35]. This treatment also sup-
pressed the vagal neuronal responses induced by
secretin and 5-HT [18,36]. To verify that perivagal appli-
cation of capsaicin was effective in ablating capsaicin-
sensitive vagal afferent fibers, using retrograde tracing,
we showed that perivagal capsaicin treatment prevented
uptake of True blue in the nodose ganglia [24]. In the
current study perivagal application of capsaicin abol-
ished the effects of CCK and peptone on the enhance-
ment of affective pain memory retention suggesting
CCK acts on capsaicin-sensitive vagal afferent C-fibers
to enhance pain memory.
In current study, we addressed a question concerning
whether CCK modulate CRD-CPA by altering the visceral
pain sensation. Behavioral visceral pain responses were
examined. We showed that the rats subjected to immedi-
ately post-conditioning CCK infusion or sham treatment
exhibited pressure-dependent increases in the CRD-
induced VMR. These responses were not significantly
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effects on the CRD-induced pain responses. Therefore, it
is highly unlikely that the enhanced retention of CPA per-
formance observed following CCK was due to alteration
of the visceral pain sensitivity.
The findings of this study raise the question as to what
physiological stimuli activate the vagal afferents that
produce this modulation of visceral pain affection. To
clarify if endogenously released CCK produce similar
effects we performed study of intra-duodenal perfusion
of peptone. In the rat, protein is the major dietary intes-
tinal stimulus for CCK release. We have characterized
that the release of CCK into the circulation is mediated
by a “CCK-releasing peptide” secreted into the intestine
of the rat [22]. We showed in this study that intraduode-
nal infusion of peptone during conditioning training
enhanced the pain memory retention. The effects were
similar to the effects of exogenous CCK administration,
and were abolished by CR-1409 suggesting postprandial
released CCK played a role in modulating pain affective
memory.
The anterior cingulated cortex (ACC) is a major cortical
component of the limbic loop system, and its functional
relationship to emotional and motivational responses have
been well described [5]. Performing single ACC neuronal
activities in response to colorectal distension (CRD) our
previous works have identified CRD-responsive neurons
in the ACC and showed that persistence of a heightened
visceral afferent nociceptive input to the ACC induced
ACC sensitization [26]. Moreover, recent studies
demonstrated that neurons in the pACC are necessary
for the “aversiveness” of visceral nociceptor stimula-
tion [6]. Since ACC activation is critical for the mem-
ory processing involved in long-term visceral negative
affective state, it is important to clarify whether ACC
is involved in the CCK-induced enhancement of pain
aversive memory. In the present study, to determine
if CCK enable to modulate ACC neuronal activities
we performed electrophysiological recording of single
ACC neuron in in vivo. We confirmed our previous
reports that rostral ACC neurons were activated by
CRD pressure-dependently. However, administration
of CCK did not change the basal ACC neuronal fir-
ings. Simultaneously infusion of CCK during colorec-
tal distension (CRD) had no effects on CRD-induced
ACC neuronal responses. Thus, CCK enhances the
visceral pain affective memory retention; this process
appears not to be mediated by alteration of ACC
neuronal responses to visceral noxious stimuli.
The most robust activation detected by fMRI following
vagus nerve stimulation was seen in the thalami and in-
sular cortices suggesting that these areas may play a role
in modulating cerebral cortical activity [37]. Currently,
the mechanisms and neuronal circuitry responsible formediating CCK-induced enhancement of visceral pain
related aversiveness memory are unclear. The pain is
likely to be reflected in a matrix of neuronal structures
rather than in a fixed pain center. A ‘neuromatrix' in-
corporating, for example, the ACC and the prefrontal
and insula cortices, amygdala and hippocampus may be
involved in the processing of pain memory without any
single region unto itself being necessary and sufficient
for the pain experience [38].
Our studies support the theory of the ongoing nature
visceral pain-induced affective disorder observed in the
clinic, such as the irritable bowel syndrome (IBS).
Altered vagal function in patients with IBS has been
reported. Findings in the current study, that feeding fa-
cilities visceral pain-related affective memory, under-
scores the importance of memory in visceral pain
perception [3,28].
Conclusions
Vagal afferent modulates negative affective aspects of
visceral pain. At physiological condition CCK activating
vagal afferent C fibers enhances visceral pain-related
affective processing and memory. Thus, in a number of
gastrointestinal disorders, such as IBS, gastrointestinal
nutrient content may contribute to painful visceral per-
ception by enhancing visceral aversive memory via
released hormones, which act on vagal afferent pathway.
Methods
Ethical approval
All experimental protocols procedures were approved by
the City University Committee on Use and Care of Animals,
and the Department of Health Hong Kong. All chemicals
were purchased from Sigma-Aldrich (St Louis, MO). Experi-
ments were performed on adult male Sprague–Dawley rats
(250–300 g). For surgical preparations, rats were anesthe-
tized with a mixture of xylazine and ketamine according to
the protocol described in our previous publication.
Conditioned place avoidance (CPA)
Place conditioning apparatus consisted of three
wooden compartments. One conditioning compartment
had horizontal stripes on the walls and an odor of
1.0% acetic acid, whereas the other had vertical stripes
and standardized cinnamon scent associated with it.
Walls of uniform color characterized and no distinct-
ive odor characterized the neutral compartment. The
experimental process consists of three distinct sessions:
a pre-conditioning session (days 1), conditioning ses-
sion (day 2–4), and post-conditioning session (e.g., test
days, 1, 3, 5 and 7 days after conditioning day) as we
described previously [6]. On the first day, rats were indi-
vidually placed in the neutral compartment and were
allowed to explore the two conditioning compartments.
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On day 1, the entrance connected to each compartment
was opened. Rat was allowed to move freely throughout
the entire apparatus (i.e., all three compartments) for 20
min. The times spent by the rat in each compartment
were recorded. Animal spending more than an 80%
(time spent >16 min) or less than 20% (time spent < 4
min) of the total time in a chamber were eliminated
from further testing (approximately 15% of total animal).
Conditioning days (days 2–4)
The conditioning phase of all experiments consisted
of 3 days. In the morning, rats received nothing, and
were randomly confined with one of the compartment
for 45 min. In the afternoon, rats received treatment
being paired with CRD 40 mm Hg or CRD 0 mm Hg
in the other conditioning compartment for 45 min. A
polyethylene tube (i.d., 1.67 mm) attached to a bal-
loon (length, 40 cm) lightly coated with a surgical lu-
bricant was placed in the colon and secured to the
base of the tail. Colorectal distension (40 mm Hg)
was produced by rapidly injecting saline into the co-
lonic balloon over 1 second and maintaining the dis-
tension for 30 seconds with 3-min interval, and
repeated five times. The 0 mm Hg CRD was served
as sham treatment.
In separate groups of rats the effects of s.c. injection of
U69,593 (a ĸ-opiofid receptor agonist) or s.c. vehicle
were paired with a distinct compartment in a place con-
ditioning apparatus.
Post-conditioning days (1, 3, 5 and 7 days after
conditioning day, test days)
The same trial was performed as pre-conditioning ses-
sion (day 1). Each rat was allowed to move freely
throughout the three compartments for 20 min with no
aversive stimulus (CRD) presented. The time spent in
each compartment was recorded.
Intravenous infusion of CCK-8
After rats were anesthetized with xylazine and ketamine
(13 and 87 mg/kg body wt, respectively), a 2-cm-long
heck incision was made, a polyethylene catheter (PE-10;
Clay-Adams PE 10,, Becton Dickinson, Sparks, MD) was
inserted into the external jugular vein and routed
through subcutaneously to the back of the neck for IV
infusion using a syringe-driven pump. The rats were
allowed to recover; the CCK studies were performed 5
days after surgery. In our previous works we have clari-
fied that intravenous infusion of CCK-8 at dose of 40
pmol/kg/h produced plasma CCK concentration mimic
the postprandial plasma CCK levels [20]. Therefore, in
the present studies, in a group of rats, CCK-8 (40 pmol/
kg/h) was infused for 15 minutes (a 250 g rat received adose of around 2.5 pmol of CCK-8) immediately follow-
ing conditioning training. The CPA studies were con-
ducted as described above.
Intra-duodenal perfusion of 5% peptone
After rats were anesthetized with xylazine and ketamine,
through a midline incision, a polyethylene cannula
(Clay-Adams PE-50) was placed into the duodenum
slightly above the sphincter of Oddi, and routed through
the abdominal wall and subcutaneously to the back of
the neck for intra-duodenal perfusion. The rats were
allowed to recover; studies were performed 5 days after
surgery. Immediately following conditioning training,
rats received an intra-duodenal perfusion of 3 ml phos-
phate-buffered saline or 3 ml 5% peptone (mol
wt<1000, pH 6.0, osmolality 300 mOsm/liter) for 15
min using a syringe-driven pump. The 5% peptone test
solution was prepared by ultrafiltration using an Amicon
membrane (YM1) and the filtrate which only contained
peptides with mol wt <1000 was used as a test solution.
Luminal perfusion peptone has been shown to release
CCK by stimulates CCK-releasing peptide secretion
[16,35].
Perivagal application of capsaicin
To investigate the role of vagal afferent pathway in the
mediation of CCK's action, we examined the effects of
perivagal application of capsaicin as we described previ-
ously [20,23,24]. Before surgery, atropine (0.5 mg/kg ip)
was administered to reduce the acute effects of capsaicin
on the cardiovascular and respiratory system. After rats
were anesthetized with xylazine and ketamine, a 3-cm-
long midline laparotomy incision was made through the
abdominal wall. The esophagus and the abdominal vagal
trunks were exposed and a piece of parafilm lamina was
placed beneath them to minimize the spread of capsaicin
to surrounding tissues. A cotton pledget soaked in cap-
saicin solution (1mg of capsaicin dissolved in 1ml of ve-
hicle (10% Tween 80 in olive oil)) was placed around the
esophagus for 30min. Capsaicin drops (0.1 ml per rat)
were applied every 5 min to keep the cotton moist. The
surgical procedure for the control animals was identical
except that only the vehicle for capsaicin (10% Tween 80
in olive oil) was perivagally applied. The area was then
thoroughly rinsed with saline and dried with sterile
swabs, and stitching was performed to help to close the
wounds. The CRD-CPA studies combined with adminis-
tration of CCK were performed 5 days after perivagal ap-
plication of capsaicin. Rats were checked for normal eye
wiping movement, which indicates that of perivagal ap-
plication of capsaicin has no systemic effect. To demon-
strate that perivagal application of capsaicin was
effective in ablating capsaicin sensitive vagal afferent
fibers, in our previous studies [24], we performed
Cao et al. Molecular Brain 2012, 5:19 Page 10 of 12
http://www.molecularbrain.com/content/5/1/19retrograde tracing studies. An aqueous suspension of
fluorescent dye, True blue was injected into the an-
terior wall of the stomach. Animals were killed 6 days
after injection for localization of the fluorescent dye.
The nodose ganglia were surgically removed; sub-
stance P immunohistochemistry studies were per-
formed for the localization of substance P. We have
shown that most of the dye was found in vagal affer-
ent neurons containing substance P immunoreactivity.
In the rats treated with perivagal capsaicin, there
were no True blue-labeled cells in the nodose ganglia
[24], which suggest that capsaicin treatment in this
study was effective in ablating vagal sensory afferent
function. Further, our previous electrophysiological
studies have demonstrated that this treatment com-
pletely abolished the CCK [23,24], secretin-, and sero-
tonin-elicited [18,36] vagal afferent neuronal response
at physiological concentrations. Perivagal application
of capsaicin also suppressed pancreatic secretion
responses induced by CCK [20,24].
Effects of CCK-A-receptor antagonist CR-1409
A polyethylene catheter (PE-10) was inserted into the
external jugular vein as described above. It has been
shown that in the anesthetized rat, the peptide antagon-
ist CR-1409 abolished cerulein-stimulated pancreatic se-
cretion in a dose-dependent manner. At a dose of 10
mg/kg, CR-1409 abolished pancreatic response to a
near-maximum dose of cerulein [39], and blocked the
vagal afferent responses to endogenous CCK stimulation
[23]. In current studies, we examined the effects of the
CCK-A-receptor antagonist CR-1409 (10 mg/kg intra-
venous bolus injection, dissolved in 0.005 N NaOH).
CR-1409 was injected before administration of CCK-8 or
luminal perfusion of peptone.
Electrophysiological recording of ACC neurons
Detailed recording procedures have been described in
our previous publications [4,26]. Briefly, anesthetized rat
was place in a stereotaxic frame, an crania opening was
made 1.0–5.0 mm anterior to bregma and 0.1–2.0 mm
lateral to midline to record neurons in the ACC. Glass
microelectrodes with tip diameters of 0.08 μm and 20–40
MΩ impedance were filled with neurobiotin and lowered
into the rostral ACC by a micromanipulator (coordi-
nates: 1.5–3.8 mm anterior to bregma, 0.3–1.0 mm lat-
eral to midline, 1.5–3.5 mm ventral to brain surface). The
rostral ACC, as defined by Vogt and Peters [5], is the
area corresponding to perigenual Brodmann area 24b,
portions of perigenual 24a, and caudodorsal area 32.
After penetrating the surface of the cortex, the record-
ing electrode was advanced until the spontaneous activ-
ity of a single unit could be accurately discriminated from
the background neuronal noise. The signals wereamplified by a high-input impedance preamplifier, dis-
played, and stored on a personal computer.
ACC neuronal activity in response to CRD
ACC neuronal spontaneous discharge was monitored for
2 min to confirm the stability of the basal firing fre-
quency. The basal firing rate was assessed over 30 s to
quantify the resting discharge in both control group and
the rats infused with CCK-8. Every neuron isolated on
the basis of spontaneous activity was studied to deter-
mine its response to CRD. The 50 mmHg CRD was pro-
duced by rapidly injecting saline into the balloon over 1
s and maintaining the distension for 30 s. A neuron was
deemed responsive to CRD if its spike firing rate
increased or decreased at least 10% from its pre-disten-
sion baseline activity. Neuronal discharge rates were
measured 30 s before, 30 s during, and 120 s after CRD,
with 5-min intervals in between, and evaluated on a time
histogram (5-s bin width). In the control group, neurons
responding to 50 mmHg CRD were tested twice to make
sure the responses were consistent and repeatable [26].
In CCK-8 treatment group, after characterizing the
CRD-excited ACC neurons, steady-state basal activity
was recorded; then, each neuron was further tested in
response to CRD with simultaneously infusion of saline
and CCK-8, respectively.
Labeling and histological identification of recording sites:
Juxtacellular injection
On completion of the experiment, recorded neurons
were labeled by injecting them with neurobiotin by the
technique of juxtacellular iontophoresis as we described
previously [26].
Visceromotor response (VMR) to colorectal distension
(CRD)
To clarify whether administration of CCK-8 or intra-
duodenal perfusion of peptone alters the visceral pain
responses we measure visceral pain in animals based on
brainstem reflexes, which have been described as “pseu-
doaffective” responses [25]. Details of this protocol were
described in our previous publications [2,3,7]. Briefly,
teflon-coated, 32-gauge stainless steel wires were
implanted into the external oblique pelvic muscles to
monitor the number of abdominal muscle contractions.
5 days after surgery graded-pressure CRD (0–20–40–60
mm Hg) was produced by rapidly injecting saline into
the colonic balloon over 1 second and maintaining the
distention for 20 seconds to establish stimulus response
curves. The results of electromyography were quantified
by calculating the area under the curve (AUC), which is
the sum of all recorded data points multiplied by the
sample interval (in seconds) after baseline subtraction.
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Statistical comparisons of the CPA data and VMR data
among different treatment groups were made using two-
way repeated-measures ANOVA followed by multiple
comparisons adjusted by the Bonferroni test. For ACC
neuronal firing, single neuronal responses were exam-
ined using Datapac 2000 (RUN Technologies, Mission
Viejo, CA, USA). The prestimulus discharge frequency
was assessed for 30s to quantify the resting discharge.
The discharge frequency during CRD was also measured
for 30s. The mean and standard deviation of ACC neur-
onal firing during the 30-s control period was compared
with the activity after CRD. Data of spontaneous firing
and firing rate to 50 mmHg CRD with saline and CCK-8
infusion were evaluated using Student’s t-test. Results
were expressed as means ± SE. P < 0.05 was considered
statistically significant.
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